StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

Stereotaxis enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Stereotaxis's enterprise value was $76.58M on Nov 11, 2026, against $207.56M a year earlier. Over the last 5 years it ranged from $72.96M to $426.92M, with a median of $148.75M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$76.58M-60.4%
2025Dec 31, 2025$193.38M+6.7%
2024Dec 31, 2024$181.20M+55.8%
2023Dec 29, 2023$116.29M-7.9%
2022Dec 30, 2022$126.24M-70.4%
2021Dec 31, 2021$426.92M+33.4%
2020Dec 31, 2020$319.93M+10.6%
2019Dec 31, 2019$289.28M+716.8%
2018Dec 31, 2018$35.42M+163.6%
2017Dec 29, 2017$13.44M+176.3%
2016Dec 30, 2016$4.86M-83.8%
2015Dec 31, 2015$30.09M-21.1%
2014Dec 31, 2014$38.15M-46.1%
2013Dec 31, 2013$70.75M+73.1%
2012Dec 31, 2012$40.88M–

More Stereotaxis figures

See a number that looks wrong?